Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy.

Patterson, K., Arya, L., Bottomley, S. et al. (4 more authors) (2016) Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy. Oncotarget, 7. pp. 76140-76150. ISSN 1949-2553

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: Copyright @ 2016 Impact Journals, LLC. All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
Keywords: RECQL5; bladder cancer; helicase; targeted therapy
Dates:
  • Accepted: 19 September 2016
  • Published (online): 15 October 2016
  • Published: October 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology and Metabolism (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:
FunderGrant number
CANCER RESEARCH UK (CRUK)C47496/A16424
Depositing User: Symplectic Sheffield
Date Deposited: 11 Nov 2016 13:23
Last Modified: 29 Jan 2018 10:07
Published Version: http://doi.org/10.18632/oncotarget.12683
Status: Published
Publisher: Impact Journals
Refereed: Yes
Identification Number: https://doi.org/10.18632/oncotarget.12683
Related URLs:

Export

Statistics